Autism Research and Support Services: Federal Interagency Coordination and Monitoring Efforts Could Be Further Strengthened
Fast Facts
We also published an "Easy Read" version of this report. Easy Read is a way of making written information easier to understand. We published the Easy Read version to make our report more accessible to certain people with autism and other intellectual and developmental disabilities.
To promote the health and well-being of people with autism, the National Institutes of Health helps coordinate the activities of 18 federal agencies—including research on contributing factors and training on how to screen patients for autism.
NIH has followed several key practices to coordinate agency programs and activities but could do more. For example, NIH could track its progress toward goals to help agencies better allocate resources where they are most needed. And NIH could document how its Office of National Autism Coordination checks for unnecessary duplication of federal efforts across agencies.
Our recommendations address this.
Highlights
What GAO Found
The National Institutes of Health (NIH), within the Department of Health and Human Services (HHS), plays a key role in supporting the coordination of autism activities across 18 federal agencies, including the Departments of Defense and Education. For example, NIH manages the Interagency Autism Coordination Committee (IACC), a federal advisory committee composed of federal agencies and public members, through its Office of National Autism Coordination.
GAO found that NIH, in support of the IACC and the National Autism Coordinator, generally followed six of eight key collaboration practices that GAO's prior work has shown can be effective in enhancing and sustaining interagency collaborative efforts among federal entities. For example, NIH has taken steps to bridge organizational cultures by convening meetings of the IACC.
Assessment of the National Institutes of Health's (NIH) Role in Supporting Coordination of Federal Autism Activities Compared with Leading Practices for Interagency Coordination
GAO found NIH efforts to support interagency coordination partially followed the remaining two collaboration practices, including ensuring accountability. For example, although IACC strategic plans describe high-level progress made toward autism activities, they generally have not described how progress made relates to goals. NIH officials stated their progress tracking approach is driven by established processes, some of which are required by law. Establishing a clear process for tracking progress would help to determine progress toward IACC's goals and that interagency efforts are effective.
NIH helps ensure federally funded autism activities are not unnecessarily duplicative through various activities, such as holding meetings and through data and information reviews. However, GAO found the processes used by NIH's Office of National Autism Coordination were not documented. For example, NIH does not have written procedures describing the steps these staff should follow when reviewing federal autism research information for potential duplication. Although NIH officials stated that they believe current monitoring processes are sufficient, documenting these procedures will help ensure they are properly designed and executed to provide reasonable assurance that duplication is not occurring.
Why GAO Did This Study
The federal government plays an important role supporting research, programs, and other activities to promote the health and well-being of people with autism. Multiple federal agencies are involved in autism activities. To help coordinate and monitor federal autism activities and to ensure activities are not unnecessarily duplicative, Congress directed the Secretary of Health and Human Services to establish the IACC and designate an official to facilitate coordination and implementation of autism activities, known as the National Autism Coordinator.
GAO was asked to examine coordination and monitoring of federal autism activities. This report examines NIH efforts to (1) help coordinate federal autism activities and (2) monitor autism activities to ensure federal autism activities are not unnecessarily duplicative.
GAO reviewed NIH documents and relevant federal laws; assessed NIH's role in supporting coordination of autism activities against key practices that GAO identified in prior work; and gathered information from 19 federal agencies that conduct autism activities.
Recommendations
GAO is making two recommendations: HHS should (1) develop a process to clearly track and report progress toward IACC goals; and (2) ensure that NIH documents the procedures its Office of National Autism Coordination uses to ensure federal autism activities are not unnecessarily duplicative. HHS concurred with the recommendations.
Recommendations for Executive Action
| Agency Affected | Recommendation | Status |
|---|---|---|
| Department of Health and Human Services | 1. The Secretary of Health and Human Services should establish a process for clearly tracking and reporting progress made toward goals established by the IACC for federal autism activities, coordinating with federal partners as appropriate. Such progress tracking should describe where performance is lagging, and why desired results were not achieved, if any. (Recommendation 1) |
HHS agreed with GAO's recommendation. We will update the status of this recommendation when HHS provides its 180 day letter (expected in summer 2024).
|
| Department of Health and Human Services | 2. The Secretary of Health and Human Services should ensure that NIH documents the procedures the Office of National Autism Coordination uses, in its support of the IACC and the National Autism Coordinator, to help ensure federal autism activities are not unnecessarily duplicative. Such documentation should describe the roles and responsibilities of different entities, sources of information used, the time frames for conducting analyses, and how outcomes will be reported. (Recommendation 2) |
HHS agreed with GAO's recommendation. We will update the status of this recommendation when HHS provides its 180 day letter (expected in summer 2024).
|